(Q35068035)

6 August 2017

1 reference

title

Liver fibrosis -- from bench to bedside (English)

1 reference

6 August 2017

Scott L Friedman

1

1 reference

6 August 2017

1 January 2003

1 reference

6 August 2017

Journal of Hepatology

1 reference

6 August 2017

38 Suppl 1

1 reference

6 August 2017

S38-53

1 reference

Transcriptional regulation of hepatic stellate cell activation

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Risk factors for the rising rates of primary liver cancer in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatocellular carcinoma: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Matrix as a modulator of hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Adult living donor liver transplantation: the hepatologist's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Host genetic factors influence disease progression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Progression of fibrosis in untreated patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Chronic hepatitis B virus infection in Asian countries

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Fibrosing cholestatic hepatitis: a report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatic expression of viral antigens, hepatocytic proliferative activity and histologic changes in liver biopsies of children with chronic hepatitis B after interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Risk factors of fibrosis in alcohol-induced liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Clinical features and natural history of nonalcoholic steatosis syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Liver fibrosis in overweight patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Reversibility of hepatic fibrosis in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatic stellate cell behavior during resolution of liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Synaptophysin: A novel marker for human and rat hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Synergism between hepatocytes and Kupffer cells in the activation of fat storing cells (perisinusoidal lipocytes)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Peroxisomal beta-oxidation and steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Peroxisome proliferator-activated receptors and hepatic stellate cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Evolving pathophysiologic concepts in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Leptin, liver, and obese mice--fibrosis in the fat lane

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Transdifferentiation of rat hepatic stellate cells results in leptin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Molecular regulation of hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Cytokine receptors and signaling in hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Expression of platelet-derived growth factor in a model of acute liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Transforming growth factors (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

The role of Smad3 in mediating mouse hepatic stellate cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Expression of connective tissue growth factor in human renal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Effects and regulation of connective tissue growth factor on hepatic stellate cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Expression of connective tissue growth factor in experimental rat and human liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatic blood flow regulation by stellate cells in normal and injured liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Intrahepatic modulation of portal pressure and its role in portal hypertension. Role of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Nitric oxide and hemodynamic impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Cellular pathophysiology of portal hypertension and prospects for management with gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Cytokines and fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation In vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-β mediated fibrogenesis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Wound-induced migration of rat hepatic stellate cells is modulated by endothelin-1 through rho-kinase-mediated alterations in the acto-myosin cytoskeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Human chemokines: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Extracellular matrix degradation and the role of hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Tissue inhibitors of metalloproteinases in liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatic stellate cells as a target for the treatment of liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatic fibrosis. Pathogenesis and principles of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Interferon gamma-1b for the treatment of idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Sho-saiko-To: the right blend of traditional Oriental medicine and liver cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Halofuginone: a novel antifibrotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900429-4

7 January 2021

10.1016/S0168-8278(02)00429-4

Identifiers

DOI

1 reference

release_xbz6p22uqnho5j4n2a5ypnw45y

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xbz6p22uqnho5j4n2a5ypnw45y

24 November 2022

mapped directly with Wikidata item

PubMed ID

12591185

1 reference

PubMed ID

12591185